Bioactive follicle-stimulating hormone
dc.contributor.author | Beitins, Inese Z. | en_US |
dc.contributor.author | Padmanabhan, Vasantha | en_US |
dc.date.accessioned | 2006-04-10T14:39:59Z | |
dc.date.available | 2006-04-10T14:39:59Z | |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Beitins, Inese Z., Padmanabhan, Vasantha (1991)."Bioactive follicle-stimulating hormone." Trends in Endocrinology and Metabolism 2(4): 145-151. <http://hdl.handle.net/2027.42/29246> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T3K-4C4FM8H-V/2/0f66b4e2bf7c197d917432ccb298602b | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29246 | |
dc.description.abstract | Specific and sensitive in vitro bioassays suitable for measurement of follicle-stimulating hormone (FSH) in small quantities of serum and urine have recently been validated. Comparisons of bioassay (B-FSH) potencies with immunoassay (I-FSH) estimates and chromatofocusing patterns have facilitated new discoveries regarding the regulation of FSH biosynthesis, storage, secretion, serum concentrations and target cell responsiveness, plasma clearance, and the significance of excreted forms. A review of recent studies reveals that luteinizing hormone and FSH, as well as B-FSH and I-FSH, appear to be differentially regulated by GnRH, GnRH agonists and antagonists, sex steroids and gonadal peptides in both sexes, with significant differences between the sexes. The results support the overall hypotheses that the quality as well as the quantity of FSH are significant contributors to target cell signal transduction and that distinct FSH isoforms with different functional capabilities influence the expression of acute (ovulation) and chronic reproductive events. | en_US |
dc.format.extent | 1239647 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Bioactive follicle-stimulating hormone | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Pediatric Endocrinology at the University of Michigan, Ann Arbor, MI 48109-0718, USA | en_US |
dc.contributor.affiliationum | Division of Pediatric Endocrinology at the University of Michigan, Ann Arbor, MI 48109-0718, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29246/1/0000303.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/1043-2760(91)90005-8 | en_US |
dc.identifier.source | Trends in Endocrinology and Metabolism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.